ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.
Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...
AstraZeneca Pharmaceuticals LP and AstraZeneca Pharmaceuticals UK Ltd. ( collectively, ..... AstraZeneca's expert, Dr. Jack Norton, testified on the topic of whether DTPA and EDTA are structurally related. ..... See J. Roger Hart et al., Chelating Agents As Preservative Potentiators, ..... LaGard, Inc., 156 F.3d 1206, 1211 (Fed.
Parties, docket activity and news coverage of federal case ATCHLEY et al v. ASTRAZENECA UK ... Defendant. ASTRAZENECA PHARMACEUTICALS LP ...
Apr 17, 2017 ... Astrazeneca Biopharmaceuticals, Inc. ... PLC; Astrazeneca, LP; and Astrazeneca Pharmaceuticals, LP (together, ... AstraZeneca, et al., No.